产品名称
DL-同型半胱氨酸, ≥95% (titration)
Quality Level
assay
≥95% (titration)
form
powder
mp
232-233 °C (lit.)
solubility
H2O: soluble
application(s)
cell analysis
peptide synthesis
storage temp.
−20°C
SMILES string
NC(CCS)C(O)=O
InChI
1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)
InChI key
FFFHZYDWPBMWHY-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
Application
DL-同型半胱氨酸已被用于诱导Sprague-Dawley大鼠的高同型半胱氨酸血症。它还被用于研究高同型半胱氨酸血症对载脂蛋白E缺陷小鼠动脉粥样硬化的影响。
Biochem/physiol Actions
同型半胱氨酸是一种含巯基的氨基酸,由甲硫氨酸合成。它是一种非必需的非蛋白原氨基酸。它是甲基化循环的重要决定因素,在血浆中有四种存在形式。同型半胱氨酸的异常高水平会导致高同型半胱氨酸血症,同时会促进动脉粥样硬化。
血浆同型半胱氨酸水平升高是冠心病和癌变的危险因素;可能是肿瘤细胞生长的标志物。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Homocysteine: role and implications in atherosclerosis.
Guthikonda S and Haynes WG
Current Atherosclerosis Reports, 8(2), 100-106 (2006)
Hyperhomocysteinemia decreases bone blood flow
Neetu Tyagi
Vascular Health, 7, 31-35 (2011)
The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health
Henrieta S
International Journal of Molecular Sciences, 17(10), 1733-1733 (2016)
Wolfgang C Winkelmayer et al.
Journal of the American Society of Nephrology : JASN, 16(1), 255-260 (2004-11-26)
Homocysteine is implicated to be an atherogenic amino acid and has been associated with increased risk of adverse cardiovascular outcomes. The prognostic significance of plasma total homocysteine (tHcy) levels for mortality and allograft loss in kidney transplant recipients has not
Role of homocysteine in the development of cardiovascular disease
Paul Ganguly and Sreyoshi Fatima Alam
Nutrition Journal, 14(6) (2015)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| H4628-1G | 04061835366965 |
| H4628-10MG | 04061833795705 |
| H4628-25G | 04061835366972 |
| H4628-5G | 04061835366989 |
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持